ENDOCRINE HEALTH LIMITED
Company number 08994426 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£164,592
Balance sheet as at 2025-03-31
What it does
The principal activity of the company is specialists medical practice activities.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2014-04-14
- Employees
- 1 (2025 accounts)
- Registered office
- Spire Hospital Bristol Redland Hill, Redland, Bristol, England, BS6 6UT
- Postcode
- BS6 6UT
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-04-14
- Next due by
- 2027-04-28
Nature of business (SIC)
- 86220 Specialists medical practice activities
Officers 1 current
Group structure 1 subsidiary
-
BRISTOL ENDOCRINE PARTNERSHIP LLP Dissolved
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA462961 (Tier 1), registered since 2019.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Previous company names
| Name | Date changed |
|---|---|
| ENDOCRINE MEDICAL LIMITED | 2014-04-29 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| 11 DUNDONALD ROAD, BRISTOL, BS6 7LN, ENGLAND | 2018-05-13 |
| 11 DUNDONALD ROAD REDLAND, BRISTOL, BS6 7JN | 2016-05-22 |
Among its peers
Top 25%
by shareholders' funds, of 326 similar companies in BS
Among the oldest 25% of its local peers, trading since 2014.
Competitors Bristol
-
5. SJ FALK LTD
This company ranks 54 among specialists medical practice activities in Bristol.
The class of 2014
45%
of the 2,104 companies in this sector incorporated in 2014 are still active today; 52% have since been dissolved.
A fact about the year, not a forecast for this company.